Cargando…

Potential of C1QTNF1-AS1 regulation in human hepatocellular carcinoma

The aim of our study is to explore the regulation of C1QTNF1-AS1 on its target miR-221-3p/SOCS3 in human hepatocellular carcinoma (HCC). To explore the underlying molecular regulation of non-coding RNA for HCC, differentially expressed patterns of lncRNAs and genes were examined by RNA-seq. GO and K...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Weijie, Yu, Guofeng, Meng, Xianmei, Hong, Hong, Zheng, Liansheng, Wu, Xiaobo, Zhang, Dongsheng, Yan, Boshi, Ma, Yongqiang, Li, Xiaolong, Wang, Qiuhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745033/ https://www.ncbi.nlm.nih.gov/pubmed/31222560 http://dx.doi.org/10.1007/s11010-019-03569-w

Ejemplares similares

Expression of a Secretory Protein C1qTNF6, a C1qTNF Family Member, in Hepatocellular Carcinoma
por: Takeuchi, Tamotsu, et al.
Publicado: (2011)

Nucleolin acts as the receptor for C1QTNF4 and supports C1QTNF4-mediated innate immunity modulation
por: Vester, Susan K., et al.
Publicado: (2021)

C1QTNF6 promotes oral squamous cell carcinoma by enhancing proliferation and inhibiting apoptosis
por: Song, Xiaobin, et al.
Publicado: (2021)

C1QTNF6 regulates cell proliferation and apoptosis of NSCLC in vitro and in vivo
por: Zhang, Wei, et al.
Publicado: (2021)

IFI44L and C1QTNF5 as promising biomarkers of proliferative diabetic retinopathy
por: Shang, Mingxin, et al.
Publicado: (2022)

High C1QTNF1 expression mediated by potential ncRNAs is associated with poor prognosis and tumor immunity in kidney renal clear cell carcinoma
por: Qiu, Jiechuan, et al.
Publicado: (2023)

C1QTNF6 Overexpression Acts as a Predictor of Poor Prognosis in Bladder Cancer Patients
por: Zhu, Xin, et al.
Publicado: (2020)

Elevated Plasma Levels of C1qTNF1 Protein in Patients with Age-Related Macular Degeneration and Glucose Disturbances
por: Budnik, Agnieszka, et al.
Publicado: (2022)

C1QTNF3 is Upregulated During Subcutaneous Adipose Tissue Remodeling and Stimulates Macrophage Chemotaxis and M1-Like Polarization
por: Micallef, Peter, et al.
Publicado: (2022)

Depletion of Mitochondrial DNA Stabilizes C1qTNF-Related Protein 6 mRNA in Muscle Cells
por: Kim, Mi-Jin, et al.
Publicado: (2012)

C1QTNF6 is a Prognostic Biomarker and Related to Immune Infiltration and Drug Sensitivity: A Pan-Cancer Analysis
por: Liu, Wei, et al.
Publicado: (2022)

Characterisation of a C1qtnf5 Ser163Arg Knock-In Mouse Model of Late-Onset Retinal Macular Degeneration
por: Shu, Xinhua, et al.
Publicado: (2011)

Novel pathogenic mutations in C1QTNF5 support a dominant negative disease mechanism in late-onset retinal degeneration
por: Stanton, Chloe M., et al.
Publicado: (2017)

African swine fever virus infection activates inflammatory responses through downregulation of the anti-inflammatory molecule C1QTNF3
por: Lv, Changjie, et al.
Publicado: (2022)

Long Non-Coding RNA C1QTNF1 Antisense RNA 1 Upregulates Hexokinase 2 by Sponging microRNA-484 to Promote the Malignancy of Colorectal Cancer
por: Jin, Shifeng, et al.
Publicado: (2020)

C1QTNF6 regulated by miR‐29a-3p promotes proliferation and migration in stage I lung adenocarcinoma
por: Lin, Guofu, et al.
Publicado: (2022)

Long Non-Coding RNA C1QTNF1 Antisense RNA 1 Upregulates Hexokinase 2 by Sponging microRNA-484 to Promote the Malignancy of Colorectal Cancer [Retraction]
Publicado: (2021)

MiR-29b-3p promotes particulate matter-induced inflammatory responses by regulating the C1QTNF6/AMPK pathway
por: Wang, Jian, et al.
Publicado: (2020)

miR-214–5p/C1QTNF1 axis enhances PCV2 replication through promoting autophagy by targeting AKT/mTOR signaling pathway
por: Cao, Yue, et al.
Publicado: (2022)

Autosomal Dominant Gyrate Atrophy-Like Choroidal Dystrophy Revisited: 45 Years Follow-Up and Association with a Novel C1QTNF5 Missense Variant
por: Kellner, Ulrich, et al.
Publicado: (2021)

Long non‐coding RNA H19 promotes leukocyte inflammation in ischemic stroke by targeting the miR‐29b/C1QTNF6 axis
por: Li, Guangwen, et al.
Publicado: (2022)

A C1qTNF3 collagen domain fusion chaperones diverse secreted proteins and anti-Aβ scFvs: Applications for gene therapies
por: Moore, Brenda D., et al.
Publicado: (2023)

Deregulated AJAP1/β-catenin/ZEB1 signaling promotes hepatocellular carcinoma carcinogenesis and metastasis
por: Han, Jihua, et al.
Publicado: (2017)

RankProd Combined with Genetic Algorithm Optimized Artificial Neural Network Establishes a Diagnostic and Prognostic Prediction Model that Revealed C1QTNF3 as a Biomarker for Prostate Cancer
por: Hou, Qi, et al.
Publicado: (2018)

Long noncoding RNA MSC‐AS1 promotes hepatocellular carcinoma oncogenesis via inducing the expression of phosphoglycerate kinase 1
por: Cao, Cong, et al.
Publicado: (2020)

FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1
por: Shi, Weidong, et al.
Publicado: (2020)

Significance of PD-L1 clones and C-MET expression in hepatocellular carcinoma
por: Chun, Hyung-Wook, et al.
Publicado: (2019)

Identification of Potential Biomarkers From Hepatocellular Carcinoma With MT1 Deletion
por: Zhang, Ruohao, et al.
Publicado: (2021)

POH1 contributes to hyperactivation of TGF-β signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF-β receptors and caveolin-1
por: Wang, Boshi, et al.
Publicado: (2019)

Expression and Clinical Significance of ERCC1 and XPF in Human Hepatocellular Carcinoma
por: Liao, Xiaoli, et al.
Publicado: (2020)

Clinical usefulness of alpha-1-antitrypsin in the diagnosis of hepatocellular carcinoma.
por: Hong, W. S., et al.
Publicado: (1991)

Oncogenic tuftelin 1 as a potential molecular-targeted for inhibiting hepatocellular carcinoma growth
por: Wu, Meng-Na, et al.
Publicado: (2021)

Cancer-Associated Fibroblasts Promote Vascular Invasion of Hepatocellular Carcinoma via Downregulating Decorin-integrin β1 Signaling
por: Zheng, Xiaobo, et al.
Publicado: (2021)

Targeting SIRT1 synergistically improves the antitumor effect of JQ-1 in hepatocellular carcinoma
por: Jiang, Yuancong, et al.
Publicado: (2023)

The interplay of transcriptional coregulator NUPR1 with SREBP1 promotes hepatocellular carcinoma progression via upregulation of lipogenesis
por: Wang, Yongjia, et al.
Publicado: (2022)

C1GALT1 Promotes Invasive Phenotypes of Hepatocellular Carcinoma Cells by Modulating Integrin β1 Glycosylation and Activity
por: Liu, Chiung-Hui, et al.
Publicado: (2014)

AKR1C1 overexpression leads to lenvatinib resistance in hepatocellular carcinoma
por: Gao, Cheng, et al.
Publicado: (2023)

Sigma‐1 receptor protects against ferroptosis in hepatocellular carcinoma cells
por: Bai, Tao, et al.
Publicado: (2019)

GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma
por: Sun, Hong-Wei, et al.
Publicado: (2016)

MEX3C as a potential target for hepatocellular carcinoma drug and immunity: combined therapy with Lenvatinib
por: Guo, Jinhui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6026h7792g57v5c0f60ve794rb